| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 高分子材料(元) | 170,321,646.54 | 81,147,103.84 | 178,675,357.90 | 71,294,589.06 |
| 医药服务(元) | 107,749,816.14 | 67,397,043.14 | 145,281,752.51 | 71,492,742.29 |
| 医药自有(含进口)(元) | 2,432,465,528.23 | 1,030,724,820.52 | 2,032,517,599.05 | 852,393,414.37 |
| 原料药(元) | 799,718,592.51 | 415,975,566.18 | 787,256,947.71 | 412,542,875.80 |
| 医药其他产品(元) | 557,851,750.52 | 348,804,770.49 | 692,909,142.57 | 361,624,074.11 |
| 营业成本(元) | ||||
| 高分子材料(元) | - | - | - | - |
| 医药服务(元) | - | - | - | - |
| 医药自有(含进口)(元) | 1,044,695,946.18 | 390,669,761.33 | 804,370,266.85 | 320,486,478.31 |
| 原料药(元) | 420,084,086.98 | 204,500,395.28 | 364,813,301.47 | 165,089,357.79 |
| 医药其他产品(元) | 438,846,452.97 | 269,095,523.52 | 527,947,845.47 | 279,219,578.11 |
| 毛利(元) | ||||
| 高分子材料(元) | - | - | - | - |
| 医药服务(元) | - | - | - | - |
| 医药自有(含进口)(元) | 1,387,769,582.05 | 640,055,059.19 | 1,228,147,332.20 | 531,906,936.06 |
| 原料药(元) | 379,634,505.53 | 211,475,170.90 | 422,443,646.24 | 247,453,518.01 |
| 医药其他产品(元) | 119,005,297.55 | 79,709,246.97 | 164,961,297.10 | 82,404,496.00 |
| 毛利率(%) | ||||
| 高分子材料(%) | - | - | - | - |
| 医药服务(%) | - | - | - | - |
| 医药自有(含进口)(%) | 57.05 | 62.10 | 60.42 | 62.40 |
| 原料药(%) | 47.47 | 50.84 | 53.66 | 59.98 |
| 医药其他产品(%) | 21.33 | 22.85 | 23.81 | 22.79 |
| 收入构成(%) | ||||
| 高分子材料(%) | 4.19 | 4.17 | 4.66 | 4.03 |
| 医药服务(%) | 2.65 | 3.47 | 3.79 | 4.04 |
| 医药自有(含进口)(%) | 59.79 | 53.02 | 52.98 | 48.18 |
| 原料药(%) | 19.66 | 21.40 | 20.52 | 23.32 |
| 医药其他产品(%) | 13.71 | 17.94 | 18.06 | 20.44 |
| 毛利构成(%) | ||||
| 高分子材料(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| 医药服务(%) | 0.00 | 0.00 | 0.00 | 0.00 |
| 医药自有(含进口)(%) | 73.57 | 68.73 | 67.65 | 61.72 |
| 原料药(%) | 20.12 | 22.71 | 23.27 | 28.71 |
| 医药其他产品(%) | 6.31 | 8.56 | 9.09 | 9.56 |